NCT01713920View on ClinicalTrials.gov

Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM

PHASE4CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Hypertension
Interventions
DRUG

SEVIKAR

Trial Locations (2)

Unknown

The Catholic University of Korea Bucheon St. Mary's Hospital, Bucheon-si

The Catholic University of Korea Seoul St. Mary's Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Daiichi Sankyo Korea Co., Ltd.

INDUSTRY

collaborator

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

lead

Sang Hyun Ihm, MD PhD

OTHER

NCT01713920 - Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM | Biotech Hunter | Biotech Hunter